Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan focused on addressing patient needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. We aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website here.
Job Overview
The Sr. Director, Medical Strategy (Rare Disease) will be a key member of the Medical Affairs team reporting to the Executive Director, Medical Affairs Strategy. This role is responsible for strategic direction and management for RETHYMIC (allogeneic processed thymus tissue–agdc), indicated for immune reconstitution in pediatric patients with congenital athymia.
The role will provide set Medical Strategy for both internal company programs and external facing HCP and Payer interactions. The Sr. Director of Medical Affairs develops and maintains professional relationships with key physicians and other health care providers to conduct external scientific information exchange, gain clinical and scientific insights, and help identify unmet medical needs.
This job will effectively lead and communicate with cross-functional team members to share and gain insights that help SMPA meet the unmet medical needs of this ultra-rare disease community. The role will also collaborate closely with Commercial leadership and advance patient advocacy efforts to ensure that Medical Affairs activities align with patient focused programs.
Job Duties and Responsibilities
Key Core Competencies
Education and Experience
The base salary range for this role is $274,800 to $343,500. Total compensation will depend on elements unique to each candidate.
Equal Employment Opportunity (EEO)
Sumitomo Pharma America (SMPA) is committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to any characteristic protected by law.
#J-18808-Ljbffr